Abstract
Stage I pancreatic cancer should be resected with curative intention. Neoadjuvant as well as adjuvant chemoradiotherapies are evaluated in ongoing studies. Palliative endoscopic and surgical interventions as well as adequate pain management and nutrition should predominate therapy of patients suffering from advanced tumors. Preliminary results of ongoing studies indicate better local control of tumor growth by chemo- and chemoradiotherapies in patients with stage II/III disease. Selected patients suffering from stage IV tumors should only be treated in controlled studies. New drugs i.e. gemcytabine and taxotere as well as combination therapies, hormones, cytokines, and monoclonal antibodies are being evaluated.
| Translated title of the contribution | Palliative therapy of locally advanced and metastasized pancreatic cancer. The state of the art |
|---|---|
| Original language | German |
| Pages (from-to) | 171-179 |
| Number of pages | 9 |
| Journal | Tumor Diagnostik und Therapie |
| Volume | 16 |
| Issue number | 5 |
| State | Published - 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Palliative therapy of locally advanced and metastasized pancreatic cancer. The state of the art'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver